Search this site
Embedded Files
Skip to main content
Skip to navigation
CREST Innovation
Home
SACHRP
Informed Consent
Special Populations
Recruitment
Clinical Trials
Research Considerations
Reliance/Collaborations
Privacy/Confidentiality
IRB Review Considerations
FDA
Information Sheets
FAQ
Guidance
OHRP
Informed Consent
Special Populations
Research Considerations
Reliance/Collaborations
Privacy/Confidentiality
IRB Review Considerations
NIH
DoD
HRSO
CREST Innovation
Home
SACHRP
Informed Consent
Special Populations
Recruitment
Clinical Trials
Research Considerations
Reliance/Collaborations
Privacy/Confidentiality
IRB Review Considerations
FDA
Information Sheets
FAQ
Guidance
OHRP
Informed Consent
Special Populations
Research Considerations
Reliance/Collaborations
Privacy/Confidentiality
IRB Review Considerations
NIH
DoD
HRSO
More
Home
SACHRP
Informed Consent
Special Populations
Recruitment
Clinical Trials
Research Considerations
Reliance/Collaborations
Privacy/Confidentiality
IRB Review Considerations
FDA
Information Sheets
FAQ
Guidance
OHRP
Informed Consent
Special Populations
Research Considerations
Reliance/Collaborations
Privacy/Confidentiality
IRB Review Considerations
NIH
DoD
HRSO
IRB Review and Ethical Considerations
SACHRP The Protection of Non-Subjects from Research Harm _ HHS.gov.pdf
SACHRP Recommendation on Revision to Recombinant DNA Guidelines _ HHS.gov.pdf
SACHRP Consideration of the Principle of Justice 45 CFR part 46 _ HHS.gov.pdf
SACHRP Attachment C_ SACHRP Recommend _ HHS.gov.pdf
SACHRP Attachment A_ Recommendation on Applicability of FDA Regulations _ HHS.gov.pdf
SACHRP Attachment A_ Approved by SACHRP July 20, 2011 _ HHS.gov.pdf
SACHRP Attachment A - IRB Authority to Restrict Use of Data Collected _ HHS.gov.pdf
SACHRP Appendix_ Understanding Minimal Risk _ HHS.gov.pdf
SACHRP Appendix F_ Administrative burden of IRB waiver of the authorizat _ HHS.gov.pdf
Google Sites
Report abuse
Page details
Page updated
Google Sites
Report abuse